Some clinical trials draw a conclusion that upfront brain RT based on first-line EGFR-TKIs might improve intra-cranial PFS but not OS in EGFR-mutant lung adenocarcinoma patients with BMs [18,19,20]. Here, EGFR is linked to lung adenocarcinoma.